What is the all-time high and low for Edwards Lifesciences stock?
The all-time high Edwards Lifesciences stock closing price was 130.58 on December 27, 2021. The Edwards Lifesciences 52-week high stock price is 130.90, which is 1.2% above the current share price. The Edwards Lifesciences 52-week low stock price is 78.44, which is 39.4% below the current share price.
What are analysts'price targets for Edwards Lifesciences stock?
20 equities research analysts have issued 12 month price targets for Edwards Lifesciences' stock. Their forecasts range from $120.00 to $250.00. On average, they expect Edwards Lifesciences' share price to reach $204.8889 in the next year.
Who holds Edwards Lifesciences'stock?
Only 1.35% of the stock of Edwards Lifesciences is held by insiders. 80.79% of the stock of Edwards Lifesciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Edwards Lifesciences are expected to grow by 11.95% in the coming year, from $2.26 to $2.53 per share.
When is Edwards Lifesciences'next quarterly earnings announcement?
Edwards Lifesciences is scheduled to release its next quarterly earnings announcement on Wednesday, January 26th 2022. View our earnings forecast for Edwards Lifesciences. How were Edwards Lifesciences' earnings last quarter? Edwards Lifesciences Co. (NYSE:EW) announced its earnings results on Wednesday, October, 27th.
Is Edwards Lifesciences stock a buy?
Edwards Lifesciences has received a consensus rating of Buy. The company's average rating score is 2.86, and is based on 19 buy ratings, 3 hold ratings, and no sell ratings.
Why is EDS Lifesciences stock dropping?
Edwards Lifesciences Corp.'s (NYSE:EW) share price tanked Tuesday, a day after saying third-quarter revenue would fall short of its prior guidance due to weaker heart valve sales. Shares, in Tuesday pre-market trade, lost 14.81 per cent to $91.50 on the New York Stock Exchange.
Does Edwards Lifesciences pay a dividend?
Edwards Lifesciences has never paid any cash dividends on its capital stock and has no current plans to pay any cash dividends. Our current policy is to retain any future earnings to fund the growth and expansion of our business.
Will Edwards Lifesciences stock split?
On May 7, 2020, during the annual shareholder meeting, stockholders approved the company's plan to execute a 3-for-1 stock split.
Is anavex a buy?
Anavex Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Why did Avxl stock go up?
Anavex Life Sciences (AVXL) surged Monday on a positive study in Rett Syndrome, helping AVXL stock extend a triple-digit gain over a five-week rally. The biotech company is working on a treatment for Rett Syndrome, a neurological disorder that affects almost exclusively girls.
Should I buy or sell Edwards Lifesciences stock right now?
22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Edwards Lifesciences in the last twelve months. There are curren...
What is Edwards Lifesciences' stock price forecast for 2022?
22 brokerages have issued 1-year price targets for Edwards Lifesciences' shares. Their forecasts range from $105.00 to $145.00. On average, they ex...
How has Edwards Lifesciences' stock price performed in 2022?
Edwards Lifesciences' stock was trading at $129.55 at the beginning of 2022. Since then, EW shares have decreased by 28.2% and is now trading at $9...
Are investors shorting Edwards Lifesciences?
Edwards Lifesciences saw a increase in short interest in May. As of May 31st, there was short interest totaling 6,560,000 shares, an increase of 27...
When is Edwards Lifesciences' next earnings date?
Edwards Lifesciences is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for...
How were Edwards Lifesciences' earnings last quarter?
Edwards Lifesciences Co. (NYSE:EW) released its quarterly earnings results on Tuesday, April, 26th. The medical research company reported $0.60 EPS...
When did Edwards Lifesciences' stock split? How did Edwards Lifesciences' stock split work?
Shares of Edwards Lifesciences split before market open on Friday, May 29th 2020. The 3-1 split was announced on Thursday, May 7th 2020. The newly...
What guidance has Edwards Lifesciences issued on next quarter's earnings?
Edwards Lifesciences issued an update on its FY22 earnings guidance on Tuesday, April, 26th. The company provided earnings per share (EPS) guidance...
Who are Edwards Lifesciences' key executives?
Edwards Lifesciences' management team includes the following people: Mr. Michael A. Mussallem , Chairman & CEO (Age 69, Pay $2.88M) Mr. Scott B....
Is EDWARDS LIFESCIENCES Stock a good buy in 2022, according to Wall Street analysts?
The consensus among 15 Wall Street analysts covering ( NYSE : EW ) stock is to Strong Buy EW stock. Out of 15 analysts , 9 ( 60% ) are re...
What is EW's earnings growth forecast for 2022-2024?
( NYSE : EW ) EDWARDS LIFESCIENCES 's forecast annual earnings growth rate of 8.92% is not forecast to beat the US Medical Devices industry...
What is EW's revenue growth forecast for 2022-2024?
( NYSE : EW ) EDWARDS LIFESCIENCES 's forecast annual revenue growth rate of 9.73% is forecast to beat the US Medical Devices industry's ave...
What is EW's forecast return on assets (ROA) for 2022-2025?
(NYSE: EW) forecast ROA is 25.92%, which is higher than the forecast US Medical Devices industry average of 14.02%.
What is EW's Price Target?
According to 15 Wall Street analyst s that have issued a 1 year EW price target, the average EW price target is $131.87 , with the highest...
What is EW's Earnings Per Share (EPS) forecast for 2022-2024?
(NYSE: EW) EDWARDS LIFESCIENCES's current Earnings Per Share (EPS) is $2.48. On average, analysts forecast that EW's EPS will be $2.57 for 2022, wi...
What is EW's forecast return on equity (ROE) for 2022-2025?
(NYSE: EW) forecast ROE is 37.34%, which is considered strong.
How much does Edwards Lifesciences make?
What is Edwards Lifesciences Corp?
Edwards Lifesciences has a market capitalization of $67.69 billion and generates $4.39 billion in revenue each year. The medical research company earns $823.40 million in net income (profit) each year or $1.86 on an earnings per share basis.
What is the P/E ratio of Edwards Lifesciences?
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
What is the EW symbol?
The P/E ratio of Edwards Lifesciences is 48.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.13.
When will Edwards stock split?
Edwards Lifesciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."
Does Edwards Lifesciences pay dividends?
Edwards Lifesciences's stock split before market open on Friday, May 29th 2020. The 3-1 split was announced on Thursday, May 7th 2020. The newly issued shares were issued to shareholders after the market closes on Monday, May 18th 2020. An investor that had 100 shares of Edwards Lifesciences stock prior to the split would have 300 shares after the split.
Analyst price target for EW
Edwards Lifesciences does not currently pay a dividend.
EW earnings per share forecast
Based on 15 analyst s offering 12 month price targets for Edwards Lifesciences Corp.
EW revenue forecast
What is EW 's earnings per share in the next 3 years based on estimates from 11 analyst s?
EW earnings growth forecast
What is EW 's revenue in the next 3 years based on estimates from 10 analyst s?
EW revenue growth forecast
How is EW forecast to perform vs Medical Devices companies and vs the US market?
Historical and forecast chart of Edwards Lifesciences stock
How is EW forecast to perform vs Medical Devices companies and vs the US market?
Edwards Lifesciences Daily Price Targets
The chart below shows the historical price of Edwards Lifesciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast.
Edwards Lifesciences information and performance
Forecast target price for 02-19-2022: $ 110.59. Negative dynamics for Edwards Lifesciences shares will prevail with possible volatility of 1.133%.
Summary
Edwards Lifesciences Corporation provides products and technologies for the treatment of structural heart disease as well as intensive care and surgical monitoring in the United States, Europe, Japan and worldwide.
Investment Thesis
There are medical emergency times when both a National Emergency and a Personal Emergency must have attention. People skills, facilities, time will be shared to preserve life.
Company description
Active investing is drawn to real life, where values get naked, often stripped of psychology and elegant marketing by power, perseverance, and necessity.
Comparing Alternative Investments
"Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves.
Investment Candidates' Prior Profitability Prospect
Readers familiar with our analysis methods may wish to skip to the next section viewing price range forecast trends for EW.
Conclusion
This comparison map uses an orientation similar to that of Figure 1, where the more desirable locations are down and to the right. Instead of price direction, the questions are more qualitative: “how big” and “how likely” are price change expectations now?